Business Standard

Biological E gets approval to manufacture J&J Covid-19 vaccine in India

According to sources, discussions are on between J&J and the Centre on the matter of indemnity against any serious adverse effect after vaccination

Johnson & Johnson
Premium

Sohini Das Mumbai
Johnson & Johnson’s (J&J’s) arm Janssen’s Covid-19 vaccine has received permission for imports, while its local partner Biological E has got approval to start manufacturing the vaccine at its facility in Telangana. How­ever, there is no clarity yet on when the vaccine would be available in India or whether the matter on indemnity has been amicably settled.
 
According to sources, discussions are on between J&J and the Centre on the matter of indemnity against any serious adverse effect after vaccination. The J&J single-dose vaccine is ex­pected to be imported for ‘fill and finish’. This means that a local partner

Don't miss the most important news and views of the day. Get them on our Telegram channel

First Published: Sep 16 2021 | 11:30 PM IST

Explore News

To read the full story, subscribe to BS Premium now, at just Rs 249/ month.

Key stories on business-standard.com are available only to BS Premium subscribers.

Register to read more on Business-Standard.com